Barinthus Biotherapeutics plc
BRNS
$1.20
$0.0151.27%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 86.26M | 99.12M | 110.66M | 106.10M | 117.77M |
| Total Receivables | 5.01M | 3.86M | 7.14M | 21.02M | 5.67M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 6.35M | 5.01M | 5.86M | 7.06M | 7.81M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2.79M | 1.90M | 2.08M | 464.00K | 626.00K |
| Total Current Assets | 100.41M | 109.88M | 125.74M | 134.65M | 131.88M |
|
|
|||||
| Total Current Assets | 100.41M | 109.88M | 125.74M | 134.65M | 131.88M |
| Net Property, Plant & Equipment | 7.84M | 10.06M | 11.76M | 18.16M | 18.25M |
| Long-term Investments | -- | -- | -- | 12.21M | 12.21M |
| Goodwill | -- | -- | -- | 12.21M | 12.21M |
| Total Other Intangibles | 20.37M | 21.16M | 21.95M | 22.74M | 23.53M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 944.00K | 902.00K | 881.00K | 926.00K | 886.00K |
| Total Assets | 129.56M | 142.00M | 160.33M | 188.69M | 186.75M |
|
|
|||||
| Total Accounts Payable | 1.80M | 1.36M | 2.47M | 3.08M | 2.56M |
| Total Accrued Expenses | 7.36M | 7.20M | 9.53M | 7.97M | 10.28M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.04M | 1.96M | 1.92M | 1.99M | 1.92M |
| Total Finance Division Other Current Liabilities | 1.53M | 1.46M | 1.74M | 2.04M | 839.00K |
| Total Other Current Liabilities | 1.53M | 1.46M | 1.74M | 2.04M | 839.00K |
| Total Current Liabilities | 12.73M | 11.98M | 15.66M | 15.07M | 15.59M |
|
|
|||||
| Total Current Liabilities | 12.73M | 11.98M | 15.66M | 15.07M | 15.59M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 9.95M | 9.96M | 10.09M | 10.68M | 10.65M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 4.40M | 4.47M | 4.45M | 3.47M | 3.72M |
| Total Liabilities | 27.08M | 26.40M | 30.19M | 29.23M | 29.96M |
|
|
|||||
| Common Stock & APIC | 393.66M | 393.95M | 393.48M | 391.88M | 390.27M |
| Retained Earnings | -278.44M | -257.31M | -237.66M | -217.12M | -209.01M |
| Treasury Stock & Other | -12.85M | -21.14M | -25.78M | -15.47M | -24.65M |
| Total Common Equity | 102.38M | 115.49M | 130.03M | 159.29M | 156.62M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 102.38M | 115.49M | 130.03M | 159.29M | 156.62M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 104.00K | 99.00K | 106.00K | 167.00K | 172.00K |
| Total Equity | 102.48M | 115.59M | 130.14M | 159.46M | 156.79M |
|
|
|||||